" class="no-js "lang="en-US"> Gene Therapies Archives - Medtech Alert
Monday, June 17, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Beacon Therapeutics Launches with £96 million to Develop a New Generation of Gene Therapies

Beacon Therapeutics, a leading ophthalmic gene therapy company with a purpose to restore and improve […]

Rentschler Biopharma Joins Forces with Ikarovec to Accelerate Novel Gene Therapies for Treatment of Ophthalmic Disease

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including […]

Cellular Origins launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell […]

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases

Ray Therapeutics, a leading optogenetics company, today announced an upsized and oversubscribed $100M Series A […]

NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies

NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]

Center for Breakthrough Medicines Now Provides a Clinically Tested Adherent Manufacturing Platform for AAV Production

The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to […]

VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies

VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck […]

Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]

Genprex CEO Commends FDA's Initiative to Accelerate Approval Process for Gene Therapies

Rodney Varner, CEO of Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies […]

Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease

Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more